NCI-COG Pediatric MATCH (Molecular Analysis For Therapy Choice)- Phase 2 Subprotocol of Ly3023414 in Patients With Solid Tumors
Phase of Trial: Phase II
Latest Information Update: 26 Dec 2018
At a glance
- Drugs LY 3023414 (Primary)
- Indications CNS cancer; Ependymoma; Germ cell and embryonal neoplasms; Glioma; Langerhans cell histiocytosis; Medulloblastoma; Neuroblastoma; Non-Hodgkin's lymphoma; Osteosarcoma; Rhabdomyosarcoma; Soft tissue sarcoma; Solid tumours; Wilms' tumour
- Focus Therapeutic Use
- Acronyms Pediatric MATCH
- 31 Aug 2018 Biomarkers information updated
- 09 Apr 2018 Planned End Date changed from 31 Dec 2021 to 30 Sep 2024.
- 09 Apr 2018 Planned primary completion date changed from 31 Dec 2021 to 30 Sep 2024.